Finance

Lists
Why is 002720 down 3,39%?
Dive Deeper
002720:KRX
Kukje Pharma Co Ltd
3 985,00 KRW
-3,39%
(-140,00) 1D
19 ოქტ, 15:30:21 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 002720...
Open
4 100 KRW
High
4 200 KRW
Low
3 850 KRW
Mkt. cap
84,32 მლრდ.
Avg. vol.
3,47 მლნ.
Volume
2,05 მლნ.
Dividend
0,75%
Quarterly dividend
8 KRW
Ex-dividend date
12 მარ. 2026
P/E ratio
16,70
52-wk high
5 470 KRW
52-wk low
2 810 KRW
EPS
239 KRW
Shares outstanding
21,16 მლნ.
No. of employees
267
Open
4 100 KRW
High
4 200 KRW
Low
3 850 KRW
Mkt. cap
84,32 მლრდ.
Avg. vol.
3,47 მლნ.
Volume
2,05 მლნ.
Dividend
0,75%
Quarterly dividend
8 KRW
Ex-dividend date
12 მარ. 2026
P/E ratio
16,70
52-wk high
5 470 KRW
52-wk low
2 810 KRW
EPS
239 KRW
Shares outstanding
21,16 მლნ.
No. of employees
267
News stories
From web sources and news partners
About Kukje Pharma Co Ltd
CEO-
Employees267
Founded1959
Headquarters-
SectorPharmaceutical industry
Websitekukjepharm.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
45,63 მლრდ.
43,34 მლრდ.
43,98 მლრდ.
48,32 მლრდ.
Cost of goods sold
20,70 მლრდ.
21,74 მლრდ.
20,17 მლრდ.
21,41 მლრდ.
Cost of revenue
20,70 მლრდ.
21,74 მლრდ.
20,17 მლრდ.
21,41 მლრდ.
Research and development expenses
658,59 მლნ.
1,79 მლრდ.
931,78 მლნ.
1,34 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,13 მლრდ.
21,36 მლრდ.
20,66 მლრდ.
23,05 მლრდ.
Operating expense
23,02 მლრდ.
23,14 მლრდ.
21,85 მლრდ.
24,77 მლრდ.
Total operating expenses
43,72 მლრდ.
44,88 მლრდ.
42,01 მლრდ.
46,18 მლრდ.
Operating income
1,92 მლრდ.
-1,54 მლრდ.
1,97 მლრდ.
2,13 მლრდ.
Other non operating income
392,85 მლნ.
195,68 მლნ.
199,95 მლნ.
268,92 მლნ.
EBT including unusual items
2,42 მლრდ.
-1,54 მლრდ.
2,62 მლრდ.
2,18 მლრდ.
EBT excluding unusual items
2,41 მლრდ.
-1,34 მლრდ.
2,60 მლრდ.
2,23 მლრდ.
Income tax expense
505,72 მლნ.
-808,40 მლნ.
477,03 მლნ.
513,17 მლნ.
Effective tax rate
20,87%
52,36%
18,20%
23,54%
Other operating expenses
-
-
-
-
Net income
1,91 მლრდ.
-731,53 მლნ.
2,15 მლრდ.
1,67 მლრდ.
Net profit margin
4,19%
-1,69%
4,88%
3,46%
Earnings per share
-
-
-
-
Interest and investment income
139,49 მლნ.
130,84 მლნ.
77,28 მლნ.
83,58 მლნ.
Interest expense
-218,61 მლნ.
-198,95 მლნ.
-188,96 მლნ.
-195,74 მლნ.
Net interest expenses
-79,12 მლნ.
-68,10 მლნ.
-111,69 მლნ.
-112,16 მლნ.
Depreciation and amortization charges
167,22 მლნ.
161,54 მლნ.
168,12 მლნ.
197,45 მლნ.
EBITDA
2,73 მლრდ.
-723,71 მლნ.
2,81 მლრდ.
3,02 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები